Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy

BACKGROUND: In recent years, a plethora of therapeutic agents for ulcerative colitis (UC), especially novel biologics (Bio), have become available. Although it is now possible to use biological drugs, there should be no need for frequently changing medications. To avoid first-pass metabolism in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibuya, Tomoyoshi, Nomura, Kei, Okahara, Koki, Haga, Keiichi, Nomura, Osamu, Murakami, Takashi, Uchida, Shino, Kodani, Tomohiro, Ishikawa, Dai, Sakamoto, Naoto, Ogihara, Tatsuo, Osada, Taro, Nagahara, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939661/
https://www.ncbi.nlm.nih.gov/pubmed/31865359
http://dx.doi.org/10.12659/MSM.918562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939661/
https://www.ncbi.nlm.nih.gov/pubmed/31865359
http://dx.doi.org/10.12659/MSM.918562

Ejemplares similares